ADAP, NasdaqGS
Adaptimmune Therapeutics plc (ADAP)
Price (as of October 24)
1.28USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Eton Pharmaceuticals, Inc. |
-0.37 |
|
Pasithea Therapeutics Corp. |
-0.35 |
|
Nektar Therapeutics |
-0.33 |
|
scPharmaceuticals Inc. |
-0.32 |
|
Celularity Inc. |
-0.3 |
|
Monopar Therapeutics Inc. |
-0.06 |
|
ChromaDex Corporation |
0.01 |
|
MoonLake Immunotherapeutics |
-0.07 |
|
BioCryst Pharmaceuticals, Inc. |
0.02 |
|
Bionomics Limited |
-0.1 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Adaptive Biotechnologies Corporation |
0.52 |
|
Affimed N.V. |
0.51 |
|
ADC Therapeutics SA |
0.46 |
|
Agios Pharmaceuticals, Inc. |
0.45 |
|
Angion Biomedica Corp. |
0.43 |
|
Celyad Oncology SA |
-0.02 |
|
ADMA Biologics, Inc. |
0.19 |
|
Akebia Therapeutics, Inc. |
0.17 |
|
vTv Therapeutics Inc. |
0.02 |
|
Albireo Pharma, Inc. |
0.23 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Travere Therapeutics, Inc. |
-0.2 |
|
Marinus Pharmaceuticals, Inc. |
-0.17 |
|
GeoVax Labs, Inc. |
-0.17 |
|
Axcella Health Inc. |
-0.16 |
|
Longboard Pharmaceuticals, Inc. |
-0.15 |
|
Merus N.V. |
0.01 |
|
Clearside Biomedical, Inc. |
-0 |
|
MannKind Corporation |
-0.03 |
|
ALX Oncology Holdings Inc. |
-0.05 |
|
Liminal BioSciences Inc. |
-0.04 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Affimed N.V. |
0.57 |
|
Alector, Inc. |
0.53 |
|
Agios Pharmaceuticals, Inc. |
0.53 |
|
Adaptive Biotechnologies Corporation |
0.51 |
|
Agenus Inc. |
0.51 |
|
Aadi Bioscience, Inc. |
0.09 |
|
ADC Therapeutics SA |
0.3 |
|
ADMA Biologics, Inc. |
0.19 |
|
AbCellera Biologics Inc. |
0.31 |
|
Albireo Pharma, Inc. |
0.23 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Longboard Pharmaceuticals, Inc. |
-0.14 |
|
GeoVax Labs, Inc. |
-0.13 |
|
Tyra Biosciences, Inc. |
-0.13 |
|
Cullinan Oncology, Inc. |
-0.11 |
|
PepGen Inc. |
-0.11 |
|
VectivBio Holding AG |
-0.11 |
|
Pardes Biosciences, Inc. |
-0.11 |
|
Genenta Science S.p.A. |
-0.1 |
|
Bionomics Limited |
-0.1 |
|
Ikena Oncology, Inc. |
-0.1 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
Agenus Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
AbCellera Biologics Inc. |
0.31 |
|
Achilles Therapeutics plc |
0.3 |
|
ADC Therapeutics SA |
0.3 |
|
Albireo Pharma, Inc. |
0.23 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
|
Alector, Inc. |
0.26 |
|
Aldeyra Therapeutics, Inc. |
0.22 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Longboard Pharmaceuticals, Inc. |
-0.14 |
|
Tyra Biosciences, Inc. |
-0.13 |
|
Cullinan Oncology, Inc. |
-0.11 |
|
PepGen Inc. |
-0.11 |
|
VectivBio Holding AG |
-0.11 |
|
Pardes Biosciences, Inc. |
-0.11 |
|
Genenta Science S.p.A. |
-0.1 |
|
Bionomics Limited |
-0.1 |
|
GeoVax Labs, Inc. |
-0.1 |
|
Ikena Oncology, Inc. |
-0.1 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
Agenus Inc. |
0.32 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
AbCellera Biologics Inc. |
0.31 |
|
Achilles Therapeutics plc |
0.3 |
|
ADC Therapeutics SA |
0.3 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
|
Alector, Inc. |
0.26 |
|
Affimed N.V. |
0.25 |
|
Akouos, Inc. |
0.23 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Eton Pharmaceuticals, Inc. |
-0.37 |
|
Pasithea Therapeutics Corp. |
-0.35 |
|
Bausch Health Companies Inc. |
-0.34 |
|
BrainsWay Ltd. |
-0.33 |
|
Nektar Therapeutics |
-0.33 |
|
scPharmaceuticals Inc. |
-0 |
|
Celularity Inc. |
-0.05 |
|
Monopar Therapeutics Inc. |
-0.06 |
|
ChromaDex Corporation |
0.01 |
|
MoonLake Immunotherapeutics |
-0.07 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Adaptive Biotechnologies Corporation |
0.52 |
|
Aclaris Therapeutics, Inc. |
0.51 |
|
Affimed N.V. |
0.51 |
|
Allied Healthcare Products, Inc. |
0.49 |
|
ADC Therapeutics SA |
0.46 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
|
Angion Biomedica Corp. |
0.01 |
|
Celyad Oncology SA |
-0.02 |
|
ADMA Biologics, Inc. |
0.19 |
|
Akebia Therapeutics, Inc. |
0.17 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Anika Therapeutics, Inc. |
-0.24 |
|
Travere Therapeutics, Inc. |
-0.2 |
|
Zhongchao Inc. |
-0.2 |
|
Marinus Pharmaceuticals, Inc. |
-0.17 |
|
TherapeuticsMD, Inc. |
-0.17 |
|
Bausch + Lomb Corporation |
-0.17 |
|
GeoVax Labs, Inc. |
-0.1 |
|
Heart Test Laboratories, Inc. |
-0.17 |
|
Axcella Health Inc. |
-0.06 |
|
Longboard Pharmaceuticals, Inc. |
-0.14 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Affimed N.V. |
0.57 |
|
Alector, Inc. |
0.53 |
|
Agios Pharmaceuticals, Inc. |
0.53 |
|
Adaptive Biotechnologies Corporation |
0.51 |
|
Agenus Inc. |
0.51 |
|
Aadi Bioscience, Inc. |
0.09 |
|
ADC Therapeutics SA |
0.3 |
|
Aclaris Therapeutics, Inc. |
0.16 |
|
ADMA Biologics, Inc. |
0.19 |
|
AbCellera Biologics Inc. |
0.31 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bausch + Lomb Corporation |
-0.17 |
|
Heart Test Laboratories, Inc. |
-0.17 |
|
Longboard Pharmaceuticals, Inc. |
-0.14 |
|
GeoVax Labs, Inc. |
-0.13 |
|
Tyra Biosciences, Inc. |
-0.13 |
|
Procaps Group S.A. |
-0.12 |
|
InMode Ltd. |
-0.12 |
|
Cullinan Oncology, Inc. |
-0.11 |
|
PepGen Inc. |
-0.11 |
|
VectivBio Holding AG |
-0.11 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
AirSculpt Technologies, Inc. |
0.33 |
|
Agenus Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
AbCellera Biologics Inc. |
0.31 |
|
Achilles Therapeutics plc |
0.3 |
|
ADC Therapeutics SA |
0.3 |
|
Albireo Pharma, Inc. |
0.23 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
|
Alignment Healthcare, Inc. |
0.27 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Bausch + Lomb Corporation |
-0.17 |
|
Heart Test Laboratories, Inc. |
-0.17 |
|
Longboard Pharmaceuticals, Inc. |
-0.14 |
|
Tyra Biosciences, Inc. |
-0.13 |
|
Procaps Group S.A. |
-0.12 |
|
InMode Ltd. |
-0.12 |
|
Cullinan Oncology, Inc. |
-0.11 |
|
PepGen Inc. |
-0.11 |
|
VectivBio Holding AG |
-0.11 |
|
Pardes Biosciences, Inc. |
-0.11 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
AirSculpt Technologies, Inc. |
0.33 |
|
Agenus Inc. |
0.32 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
AbCellera Biologics Inc. |
0.31 |
|
Achilles Therapeutics plc |
0.3 |
|
ADC Therapeutics SA |
0.3 |
|
Alignment Healthcare, Inc. |
0.27 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
|
Alector, Inc. |
0.26 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Viveon Health Acquisition Corp. |
-0.47 |
|
Cerberus Cyber Sentinel Corporation |
-0.44 |
|
LF Capital Acquisition Corp. II |
-0.42 |
|
Infinite Acquisition Corp. |
-0.41 |
|
Pearl Holdings Acquisition Corp |
-0.4 |
|
TD Holdings, Inc. |
-0 |
|
SportsTek Acquisition Corp. |
-0.03 |
|
Glass Houses Acquisition Corp. |
-0.01 |
|
Eton Pharmaceuticals, Inc. |
0.01 |
|
LifeVantage Corporation |
-0.02 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Adaptive Biotechnologies Corporation |
0.52 |
|
Aclaris Therapeutics, Inc. |
0.51 |
|
Affimed N.V. |
0.51 |
|
AAR Corp. |
0.49 |
|
Allied Healthcare Products, Inc. |
0.49 |
|
Digital Ally, Inc. |
0.07 |
|
Virtus AllianzGI Diversified Income & Convertible Fund |
0.22 |
|
Ennis, Inc. |
0.03 |
|
ADC Therapeutics SA |
0.3 |
|
Agios Pharmaceuticals, Inc. |
0.27 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Anika Therapeutics, Inc. |
-0.24 |
|
Blockchain Coinvestors Acquisition Corp. I |
-0.23 |
|
Trine II Acquisition Corp. |
-0.22 |
|
Travere Therapeutics, Inc. |
-0.2 |
|
Welsbach Technology Metals Acquisition Corp. |
-0.2 |
|
Zhongchao Inc. |
-0.05 |
|
PowerUp Acquisition Corp. |
-0.2 |
|
Papaya Growth Opportunity Corp. I |
-0.2 |
|
PowerShares DB Crude Oil Double Short ETN |
-0.07 |
|
Kadem Sustainable Impact Corporation |
-0.11 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Affimed N.V. |
0.57 |
|
Alector, Inc. |
0.53 |
|
Agios Pharmaceuticals, Inc. |
0.53 |
|
Adaptive Biotechnologies Corporation |
0.51 |
|
Agenus Inc. |
0.51 |
|
Aadi Bioscience, Inc. |
0.09 |
|
ALPHA INTELLIGENT - LARGE CAP GROWTH ETF |
0.46 |
|
ADC Therapeutics SA |
0.3 |
|
Aclaris Therapeutics, Inc. |
0.16 |
|
ADMA Biologics, Inc. |
0.19 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Blockchain Coinvestors Acquisition Corp. I |
-0.23 |
|
Trine II Acquisition Corp. |
-0.22 |
|
Welsbach Technology Metals Acquisition Corp. |
-0.2 |
|
PowerUp Acquisition Corp. |
-0.2 |
|
Papaya Growth Opportunity Corp. I |
-0.2 |
|
Intelligent Medicine Acquisition Corp. |
-0.19 |
|
Globalink Investment Inc. |
-0.19 |
|
Denali Capital Acquisition Corp. |
-0.18 |
|
Metal Sky Star Acquisition Corporation |
-0.18 |
|
Viscogliosi Brothers Acquisition Corp. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ALPHA INTELLIGENT - LARGE CAP GROWTH ETF |
0.46 |
|
Adaptive Alpha Opportunities ETF |
0.38 |
|
SMARTETFS ASIA PACIFIC DIVIDEND BUILDER ETF |
0.37 |
|
American Century Select High Yield ETF |
0.37 |
|
AI Powered Equity ETF |
0.36 |
|
NASDAQ Composite |
0.33 |
|
Global X Artificial Intelligence & Technology ETF |
0.34 |
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
ALPS Clean Energy ETF |
0.33 |
|
AirSculpt Technologies, Inc. |
0.33 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Blockchain Coinvestors Acquisition Corp. I |
-0.23 |
|
Trine II Acquisition Corp. |
-0.22 |
|
Welsbach Technology Metals Acquisition Corp. |
-0.2 |
|
PowerUp Acquisition Corp. |
-0.2 |
|
Papaya Growth Opportunity Corp. I |
-0.2 |
|
Intelligent Medicine Acquisition Corp. |
-0.19 |
|
Globalink Investment Inc. |
-0.19 |
|
Denali Capital Acquisition Corp. |
-0.18 |
|
Metal Sky Star Acquisition Corporation |
-0.18 |
|
Viscogliosi Brothers Acquisition Corp. |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ALPHA INTELLIGENT - LARGE CAP GROWTH ETF |
0.46 |
|
Adaptive Alpha Opportunities ETF |
0.38 |
|
SMARTETFS ASIA PACIFIC DIVIDEND BUILDER ETF |
0.37 |
|
American Century Select High Yield ETF |
0.37 |
|
AI Powered Equity ETF |
0.36 |
|
Global X Artificial Intelligence & Technology ETF |
0.34 |
|
Acumen Pharmaceuticals, Inc. |
0.34 |
|
ALPS Clean Energy ETF |
0.33 |
|
NASDAQ Composite |
0.33 |
|
AirSculpt Technologies, Inc. |
0.33 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company’s specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. The company is also developing ADP-A2AFP, which is in phase I clinical trials for hepatocellular carcinoma; and ADP-A2M4CD8, which is in phase I clinical trial for SPEAR T-cells focusing on treating patients with lung, gastroesophageal, head and neck, ovarian, and bladder cancers. It has a collaboration and license agreement with GSK; third party collaborations with Noile-Immune Biotech Inc., Alpine Immune Sciences, Inc., and National Center for Cancer Immune Therapy in Denmark; strategic alliance agreement with the MD Anderson Cancer Center; and co-development and co-commercialization agreement with Universal Cells, Inc. Adaptimmune Therapeutics plc also has a strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic T-cell therapies utilizing aß T-cell receptors. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.